Prosight Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-74,921	Closed	-$1.21M	–	47
2025 Q1	$1.21M	Sell	74,921 -5,079	-6%	-$82K	0.4%	33
2024 Q4	$1.86M	Buy	+80,000	New	+$1.86M	0.51%	29
2024 Q1	–	Sell	-55,000	Closed	-$1.18M	–	48
2023 Q4	$1.18M	Buy	+55,000	New	+$1.18M	0.48%	27